Genincode Plc (GENI)
LSE
Real-time Data
07:00 AM
Day's Range
0.900052 wk Range
0.7500Profile - GENI - Genincode Plc
Profile
Mic Code
AIMX
Sector
Healthcare
Industry
Diagnostics & Research
Employees
44
Genincode Plc is a biotechnology company specializing in the development and commercialization of advanced predictive genetic testing solutions. The primary function of Genincode Plc is to provide innovative and personalized healthcare solutions that focus on cardiovascular disease risk assessment. Through its cutting-edge genetic testing technologies, the company aims to offer healthcare providers and patients insights into genetic predispositions, thereby facilitating tailored medical interventions and lifestyle recommendations. Genincode Plc has a significant impact on the biotechnology and personalized medicine sectors, driving advancements in early detection and prevention strategies for cardiovascular diseases. The company's market role is vital as it addresses growing demands for personalized healthcare solutions that improve therapeutic outcomes and optimize resource allocation within the healthcare system. Operating in the UK and beyond, Genincode Plc collaborates with various healthcare institutions to expand access to its genetic testing services, reinforcing its commitment to the evolution of precision medicine.
Profile Details
Type
Common Stock
Ceo
Mr. Matthew Heaton Walls
Address
One St. Peters Square
City
Manchester
Zip
M2 3DE
Country
United Kingdom
Phone
44 1865 676 125
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
